2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.

Jørn HerrstedtL CelioP J HeskethL ZhangR NavariA ChanM SaitoR ChowM Aapro

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2023)

receptor antagonists were identified. No new antiemetic agents qualified for inclusion in the updated recommendations.

Keyphrases